RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BASSO U
Collezione AOU San Luigi di Orbassano

Items : 7

Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2025 Feb;23(1):102265. doi: 10.1016/j.clgc.2024.102265. Epub 2024 Nov 12.

2025
AOU San Luigi di Orbassano

Caffo O; Basso U; Cattrini C; Ermacora P; Maruzzo M; Alberti M; Anesi C; Bimbatti D; Cani M; Crespi V; Farinea G; Kadrija D; Kinspergher S; Lai E; Lay L; Maines F; Mennitto A; Pierantoni F; Samuelly A; Urban S; Buttigliero C; Veccia A;

Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation. in Cancer discovery / Cancer Discov. 2024 Mar 1;14(3):424-445. doi: 10.1158/2159-8290.CD-23-0754.

2024
AOU San Luigi di Orbassano

Franceschini GM; Quaini O; Mizuno K; Orlando F; Ciani Y; Ku SY; Sigouros M; Rothmann E; Alonso A; Benelli M; Nardella C; Auh J; Freeman D; Hanratty B; Adil M; Elemento O; Tagawa ST; Feng FY; Caffo O; Buttigliero C; Basso U; Nelson PS; Corey E; Haffner MC; Attard G; Aparicio A; Demichelis F; Beltran H;

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study). in Clinical Medicine Insights. Oncology / Clin Med Insights Oncol. 2021 Jul 8;15:11795549211021667. doi: 10.1177/11795549211021667. eCollectio

2021
AOU San Luigi di Orbassano

Bersanelli M; Buti S; Cortellini A; Bandini M; Banna GL; Pederzoli F; Farè E; Raggi D; Giannatempo P; De Giorgi U; Basso U; Losanno T; Santini D; Mucciarini C; Tucci M; Tambaro R; Farnesi A; Caffo O; Veccia A; Naglieri E; Briganti A; Procopio G; Pignata S; Necchi A;

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. in Future oncology (London, England) / Future Oncol. 2019 Apr;15(10):1115-1123. doi: 10.2217/fon-2018-0715. Epub 2019 Mar 19.

2019
AOU San Luigi di Orbassano

Caffo O; Facchini G; Biasco E; Ferraù F; Morelli F; Donini M; Buttigliero C; Calvani N; Guida A; Chiuri VE; Basso U; Mucciarini C; Conteduca V; Rossetti S; Veccia A; Maines F; Kinspergher S; De Giorgi U;

Cost of illness of urothelial bladder cancer in Italy. in ClinicoEconomics and outcomes research : CEOR / Clinicoecon Outcomes Res. 2017 Jul 24;9:433-442. doi: 10.2147/CEOR.S135065. eCollection 2017.

2017
AOU San Luigi di Orbassano

Gerace C; Montorsi F; Tambaro R; Cartenì G; De Luca S; Tucci M; Martorana G; Basso U; Cardosi L; Teruzzi C;

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. in Future oncology (London, England) / Future Oncol. 2016 Feb;12(4):493-502. doi: 10.2217/fon.15.302. Epub 2016 Jan 18.

2016
AOU San Luigi di Orbassano

Veccia A; Caffo O; De Giorgi U; Di Lorenzo G; Ortega C; Scognamiglio F; Aieta M; Facchini G; Mansueto G; Mattioli R; Procopio G; Zagonel V; D'Angelo A; Spizzo G; Bortolus R; Donini M; Lo Re G; Massari F; Vicario G; Zucali PA; Alesini D; Bonetti A; Mucciarini C; Nicodemo M; Berruti A; Fratino L; Lodde M; Messina C; Perin A; et alii...

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study. in European urology / Eur Urol. 2015 Jul;68(1):147-53. doi: 10.1016/j.eururo.2014.10.014. Epub 2014 Oct 25.

2015
AOU San Luigi di Orbassano

Caffo O; De Giorgi U; Fratino L; Alesini D; Zagonel V; Facchini G; Gasparro D; Ortega C; Tucci M; Verderame F; Campadelli E; Lo Re G; Procopio G; Sabbatini R; Donini M; Morelli F; Sartori D; Zucali P; Carrozza F; D'Angelo A; Vicario G; Massari F; Santini D; Sava T; Messina C; Fornarini G; La Torre L; Ricotta R; Aieta M; et alii...